Back to Results
First PageMeta Content
Fabry disease / Alpha-galactosidase / Genzyme / Enzyme replacement therapy / Amyotrophic lateral sclerosis / Rare diseases / Health / Lipid storage disorders


CFA Members GenzymeShortage
Add to Reading List

Document Date: 2012-02-26 16:46:11


Open Document

File Size: 225,04 KB

Share Result on Facebook

City

Halifax / /

Company

CBC / Genzyme Canada / Genzyme Corporation / /

Country

Canada / /

Event

Person Communication and Meetings / /

Facility

University Avenue Halifax / University Crescent Burnaby / Dickson Building / /

/

IndustryTerm

manufacturing interruption / treatment of Fabry disease / licensed product / treatment for Fabry Disease / therapy for Fabry disease / /

MedicalCondition

several other Fabry disease / Fabry Disease / /

MedicalTreatment

enzyme replacement therapy / /

Organization

Canadian Fabry Association / Dalhousie University Department of Medicine / Research Ethics Board / CFDI Study Professor Division of Nephrology Department / Dalhousie University / /

Person

Michael West / Kaye LeMoine / Toll / Darren Bidulka / /

/

Position

Fabry specialist / National Coordinator / Principal Investigator / President / regional study coordinator / Chair Scientific committee / /

Product

Fabrazyme / /

ProvinceOrState

Nova Scotia / /

Technology

antibodies / /

SocialTag